Source: Annual Congress 2009 - Sarcoidosis in review
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Aguiar, M. Felizardo, N. Marçal, A. C. Mendes, A. Bugalho de Almeida (Lisboa, Portugal). Infliximab for treating sarcoidosis, portuguese experience. Eur Respir J 2009; 34: Suppl. 53, 694

Member's Comments

No comment yet.

Related content which might interest you: Infliximab: An effective rescue therapy in refractory extra-pulmonary sarcoidosis Source: Annual Congress 2013 –Sarcoidosis and other granulomatosis Year: 2013 Efficacy of adalimumab in sarcoidosis patients who developed intolerance to infliximab Source: International Congress 2016 – Sarcoidosis Year: 2016 Infliximab therapy in patients with chronic progressive sarcoidosis – a retrospective follow-up study Source: Annual Congress 2008 - Sarcoidosis: pathophysiology and severity Year: 2008 Efficacy of infliximab in extrapulmonary sarcoidosis: results from a randomised trial Source: Eur Respir J 2008; 31: 1189-1196 Year: 2008 Corticosteroid treatment in sarcoidosis Source: Eur Respir J 2006; 28: 627-636 Year: 2006 Infliximab in patients with refractory sarcoidosis: Trough concentrations of infiximab Source: International Congress 2015 – Clinical problems in acute and chronic lung diseases Year: 2015 Therapeutic options for sarcoidosis: old and new Source: Annual Congress 2005 - PG15 - Therapeutic options for interstitial lung diseases in 2005 Year: 2005 Combined immunosuppressive therapy including anti-TNFα in a treatment of severe paediatric sarcoidosis – a case report Source: Eur Respir J 2006; 28: Suppl. 50, 829s Year: 2006 Rituximab in the treatment of refractory pulmonary sarcoidosis Source: Eur Respir J 2014; 43: 1525-1528 Year: 2014 Long-term treatment with infliximab in patients with sarcoidosis Source: Annual Congress 2011 - Different profiles of sarcoidosis and other granulomatous disorders Year: 2011 When to treat sarcoidosis Source: Eur Respir Monogr 2022; 96: 316-327 Year: 2022 Methotrexate as a single agent for the treatment of patients with progressive pulmonary sarcoidosis Source: International Congress 2015 – Sarcoidosis: clinical Year: 2015 Standard therapy for sarcoidosis Source: Annual Congress 2005 - Biological agents in the therapy of sarcoidosis Year: 2005 Infliximab treatment in a patient with rheumatoid arthritis and pulmonary fibrosis Source: Eur Respir J 2004; 24 : 708 Year: 2004 Infliximab in extrapulmonary sarcoidosis: tantalising but inconclusive Source: Eur Respir J 2008; 31: 1148-1149 Year: 2008 Management of sarcoidosis in clinical practice Source: Eur Respir Rev 2016; 25: 141-150 Year: 2016 Pulmonary manifestations in Iranian patients with chronic granulomatosis disorder Source: Eur Respir J 2007; 30: Suppl. 51, 86s Year: 2007 Two-coloured magnetic-laser therapy in sarcoidosis Source: Eur Respir J 2005; 26: Suppl. 49, 81s Year: 2005 Efficacy of traditional and combined therapy in patients with sarcoidosis Source: Eur Respir J 2003; 22: Suppl. 45, 234s Year: 2003 Effect of infliximab on lung function and well-being in patients with refractory sarcoidosis Source: Annual Congress 2011 - Different profiles of sarcoidosis and other granulomatous disorders Year: 2011